Cardiovascular involvement in pediatric systemic autoimmune diseases: The emerging role of noninvasive cardiovascular imaging

Inflammation and Allergy - Drug Targets

Volumn 13, Issue 6, 2014, Pages 371-381

  Mavrogeni, Sophie ^a   Servos, George ^b   Smerla, Roubini ^b   Markousis Mavrogenis, George ^a   Grigoriadou, Georgia ^b   Kolovou, Genovefa ^a   Papadopoulos, George ^b  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Cardiovascular magnetic resonance; Echocardiography; Nuclear medicine; Pediatric autoimmune diseases

Indexed keywords

ATORVASTATIN; CYCLOPHOSPHAMIDE; GADOLINIUM; GLUCOCORTICOID; HLA B27 ANTIGEN; RITUXIMAB;

ANKYLOSING SPONDYLITIS; AORTA ARCH SYNDROME; AORTA VALVE REGURGITATION; AORTITIS; ARTICLE; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CHRONIC INFLAMMATION; CHURG STRAUSS SYNDROME; CLINICAL TRIAL (TOPIC); COMPLETE HEART BLOCK; CORONARY ARTERY ANEURYSM; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; FOLLOW UP; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART FAILURE; HUMAN; HYPERTENSION; JUVENILE DERMATOMYOSITIS; JUVENILE RHEUMATOID ARTHRITIS; JUVENILE SCLERODERMA; MAGNETIC RESONANCE ANGIOGRAPHY; MITRAL VALVE REGURGITATION; MORTALITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDIAL DISEASE; PANCARDITIS; PATHOPHYSIOLOGY; PEDIATRICS; PERICARDIAL DISEASE; POLYMYOSITIS; PREVALENCE; RHEUMATIC FEVER; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SJOEGREN SYNDROME; SPONDYLARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; WEGENER GRANULOMATOSIS; AUTOIMMUNE DISEASES; CARDIOVASCULAR DISEASES; CHILD; COMPLICATION; DIAGNOSTIC IMAGING; PROCEDURES;

AUTOIMMUNE DISEASES; CARDIOVASCULAR DISEASES; CHILD; DIAGNOSTIC IMAGING; HUMANS; PEDIATRICS;

EID: 84988233611     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871528114999150317150050     Document Type: Article

References (90)

1. Owlia, M. B. Acute rheumatic fever, an acute or a chronic joint disease? Journal of Shahid Sadoughi University of Medical Sciences, 2011, 19, 561-567.
2. Sandoo, A.; Kitas, G. D.; Carroll, D.; Veldhuijzen van Zanten, J. J. The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study. Arthritis Res. Ther., 2012, 14(3), R117.
3. Roman, M. J.; Salmon, J. E. Cardiovascular manifestations of rheumatologic diseases. Circulation, 2007, 116 (20), 2346-2355.
4. Kitas, G.; Banks, M. J.; Bacon, P. A. Cardiac involvement in rheumatoid disease. Clin. Med., 2001, 1(1), 18-21.
5. Mayosi, B. M.; Gamra, H.; Dangou, J. M.; Kasonde, J. 2nd All-Africa Workshop on RheumaticFever and Rheumatic Heart Disease participants. Rheumatic heart disease in Africa: the Mosio-Tunya call to action. Lancet Glob Health, 2014, 2(8), e438-39.
6. Kunitomi, T.; Ikeda, M. Rheumatoid arthritis complicated with pericarditis-focused mainly on juvenile idiopathic arthritis. Nihon Rinsho., 2007, Suppl 5 (2), 458-460.
7. Movva, R.; Brown, S. B.; Morris, D. L.; Figueredo, V. M. Anakinra for myocarditis in juvenile idiopathic arthritis. Tex. Heart Inst. J., 2013, 40(5), 623-625.
8. Mavrogeni, S.; Bratis, K.; Sfendouraki, E.; Papadopoulou, E.; Kolovou, G. Myopericarditis, as the first sign of rheumatoid arthritis relapse, evaluated by cardiac magnetic resonance. Inflamm. Allergy Drug Targets, 2013, 12, 206-211.
9. Stichweh, D.; Arce, E.; Pascual, V. Update on pediatric SLE. Curr. Opin. Rheumatol., 2004, 16, 577-587.
10. Gazarian, M.; Feldman, B. M.; Benson, L. N.; Gilday, D. L.; Laxer, R. M.; Silverman, E. D. Assessment of myocardial perfusion and function in childhood systemic lupus erythematosus. J. Pediatr., 1998, 132, 109-116.
11. Kavey, R-E. W. Allada, V.; Daniels, S. R.; Hayman, L. L.; McCrindle, B. W.; Newburger, J. W.; Parekh, R. S.; Steinberger, J. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science. Circulation, 2006, 114(24), 2710-2738.
12. Asanuma, Y.; Oeser, A.; Shintani, A. K.; Turner, E.; Olsen, N.; Fazio, S.; Linton, M. F.; Raggi, P.; Stein, C. M. Premature coronaryartery atherosclerosis in systemic lupus erythematosus. N. Engl. J. Med., 2003, 349(25), 2407-2415.
13. Park, Y. B.; Ahn, C. W.; Choi, H. K.; Lee, S. H.; In, B. H.; Lee, H. C.; Nam, C. M.; Lee, S. K. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum., 2002, 46, 1714-1719.
14. Ardoin, S. P.; Schanberg, L. E.; Sandborg, C. I.; Barnhart, H. X.; Evans, G. W.; Yow, E.; Mieszkalski, K. L.; Ilowite, N. T.; Eberhard, A.; Imundo, L. F.; Kimura, Y.; Levy, D.; von Scheven, E.; Silverman, E.; Bowyer, S. L.; Punaro, L.; Singer, N. G.; Sherry, D. D.; McCurdy, D. K.; Klein-Gitelman, M.; Wallace, C.; Silver, R. M.; Wagner-Weiner, L.; Higgins, G. C.; Brunner, H. I.; Jung, L.; Soep, J. B.; Reed, A. M.; Thompson, S. D. APPLE investigators. Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein. Ann. Rheum. Dis., 2014, 73(3), 557-566.
15. Canpolat, N.; Kasapcopur, O.; Caliskan, S.; Gokalp, S.; Bor, M.; Tasdemir, M.; Sever, L.; Arisoy, N. Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenileonset systemic lupus erythematosus. Pediatr. Nephrol., 2013, 28, 305-313.
16. Owlia, M. B.; Mostafavi, P.; Manshadi, S. M. Cardiac manifestations of rheumatological conditions: a narrative review ISRN. Rheumatology, 2012, 2012, 463620.
17. Molad, Y.; Levin-Iaina, N.; Vaturi, M.; Sulkes, J.; Sagie, A. Heart valve calcification in young patients with SLE: a window to premature atherosclerotic vascular morbidity and a risk factor for all-cause mortality Atherosclerosis, 2006, 185(2), 406-412.
18. Eisen, A.; Arnson, Y.; Dovrish, Z.; Hadary, R.; Amital, H. Arrhythmias and conduction defects in rheumatological diseases-a comprehensive review Semin. Arthritis Rheum., 2009, 39(3), 145-156.
19. Buyon, J. P.; Clancy, R. M. Maternal autoantibodies and congenital heart block: mediators, markers, and therapeutic approach. Semin. Arthritis Rheum., 2003, 33, 140-154.
20. Jayaprasad, N.; Johnson, F.; Venugopal, K. Congenital complete heart block and maternal connective tissue disease. Int. J. Cardiol., 2006, 112, 153-158.
21. Guevara, J. P.; Clark, B. J.; Athreya, B. H. Point prevalence of cardiac abnormalities in children with systemic lupus erythematosus. J. Rheumatol., 2001, 28, 854-859.
22. Gunal, N.; Kara, N.; Akkok, N.; Cakar, N.; Kahramanyol, O.; Akalyn, N. Cardiac abnormalities in children with systemic lupus erythematosus. Günal Turk J. Pediatr., 2003, 45, 301-305.
23. Asanuma, Y.; Oeser, A.; Shintani, A. K.; Turner, E.; Olsen, N.; Fazio, S.; Linton, M. F.; Raggi, P.; Stein, C. M. Premature coronaryartery atherosclerosis in systemic lupus erythematosus. N. Engl. J. Med., 2003, 349(25), 2407-2415.
24. Park, Y. B.; Ahn, C. W.; Choi, H. K.; Lee, S. H.; In, B. H.; Lee, H. C.; Nam, C. M.; Lee, S. K. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum., 2002, 46, 1714-1719.
25. Schanberg, L. E.; Sandborg, C.; Barnhart, H. X.; Ardoin, S. P.; Yow, E.; Evans, G. W.; Mieszkalski, K. L.; Ilowite, N. T.; Eberhard, A.; Levy, D. M.; Kimura, Y.; von Scheven, E.; Silverman, E.; Bowyer, S. L.; Punaro, L.; Singer, N. G.; Sherry, D. D.; McCurdy, D.; Klein-Gitelman, M.; Wallace, C.; Silver, R.; Wagner-Weiner, L.; Higgins, G. C.; Brunner, H. I.; Jung, L.; Soep, J. B.; Reed, A.; for the Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators. Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Atherosclerosis Prevention for Systematic Lupus Erythematosus (APPLE) Investigators. Arthritis Rheum., 2009, 60(5), 1496-1507.
26. Huppertz, H.; Voigt, I.; Mόller-Scholden, J.; Sandhage, K. Cardiac manifestation in patients with HLA B27-associated juvenile arthritis. Pediatr. Cardiol., 2000, 21, 141-147.
27. Jimenez-Balderas, F. J.; Garcia-Rubi, D.; Perez-Hinojosa, S.; Arellano, A.; Yanez, S.; Sanchez, M. L.; Camargo-Coronel, A.; Zonana-Nacach, A. Two-dimensional echo Doppler findings in juvenile and adult onset ankylosing spondylitis with long-term disease Angiology, 2001, 52, 543-548.
28. Khraishi, M.; Aslanov, R.; Rampakakis, E.; Pollock, C.; Sampalis, J. S. Prevalence of cardiovascular risk factors in patients with psoriatic arthritis. Clin. Rheumatol., 2014, 33(10), 1495-500.
29. Torres, T.; Sales, R.; Vasconcelos, C.; Martins da Silva, B.; Selores, M. Framingham Risk Score underestimates cardiovascular disease risk in severe psoriatic patients: implications in cardiovascular risk factors management and primary prevention of cardiovascular disease. J. Dermatol., 2013, 40(11), 923-926.
30. Shang, Q.; Tam, L. S.; Sanderson, J. E.; Lee, A. P.; Li, E. K.; Yu, C. M. Impaired left ventricular apical rotation is associated with disease activity of psoriatic arthritis. J. Rheumatol., 2014, 41(4), 706-713.
31. Shang, Q.; Tam, L. S.; Yip, G. W.; Sanderson, J. E.; Zhang, Q.; Li, E. K.; Yu, C. M. High prevalence of subclinical left ventricular dysfunction in patients with psoriatic arthritis. J. Rheumatol., 2011, 38(7), 1363-1370.
32. Chang, B.; Schachna, L.; White, B.; Wigley, F. M.; Wise, R. A. Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma. J. Rheumatol., 2006, 33(2), 269-274.
33. Rabinovich, C. E. Challenges in the diagnosis and treatment of juvenile systemic sclerosis. Nat. Rev. Rheumatol., 2011, 7(11), 676-680.
34. Scalapino, K.; Arkachaisri, T.; Lucas, M.; Fertig, N.; Helfrich, D. J.; Londino, A. V. Jr.; Steen, V. D.; Medsger, T. A. Jr. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J. Rheumatol., 2006, 33(5), 1004-1013.
35. Borowiec, A.; Dabrowski, R.; Wozniak, J.; Jasek, S.; Chwyczko, T.; Kowalik, I.; Musiej-Nowakowska, E.; Szwed, H. Cardiovascular assessment of asymptomatic patients with juvenileonset localized and systemic scleroderma: 10 years prospective observation. Scand. J. Rheumatol., 2012, 41(1), 33-38.
36. Zulian, F.; Vallongo, C.; Woo, P.; Russo, R.; Ruperto, N.; Harper, J.; Espada, G.; Corona, F.; Mukamel, M.; Vesely, R.; Musiej-Nowakowska, E.; Chaitow, J.; Ros, J.; Apaz, M. T.; Gerloni, V.; Mazur-Zielinska, H.; Nielsen, S.; Ullman, S.; Horneff, G.; Wouters, C.; Martini, G.; Cimaz, R.; Laxer, R.; Athreya, B. H.; Juvenile Scleroderma Working Group of the Pediatric Rheumatology European Society (PRES). Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum., 2005, 52(9), 2873-2881.
37. Bulkley, B. H.; Ridolfi, R. L.; Salyer, W. R.; Hutchins, G. M. Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation, 1976, 53, 483-490.
38. de Macedo, P. A.; Shinjo, S. K.; Goldenstein-Schainberg, C. Juvenile scleroderma. Acta Reumatológica Portuguesa., 2008, 33(3), 289-297.
39. Martini, G.; Vittadello, F.; Kasapcopur, O.; Magni Manzoni, S.; Corona, F.; Duarte-Salazar, C.; Nemcova, D.; Len, C. A.; Garay, S. M.; Ullman, S.; Zulian, F.; for the Juvenile Scleroderma Working Group of Paediatric Rheumatology European Society (PRES). Outcome predictors in juvenile systemic Sclerosis. Rheumatology, 2009, 48, 119-122.
40. Danieli, M. G.; Gambini, S.; Pettinari, L.; Logullo, F.; Veronesi, G.; Gabrielli, A. Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long term follow-up study. Autoimmun Rev., 2014, 13(10), 1048-1054.
41. Stern, R.; Godbold, J. H.; Chess, Q.; Kagen, L. J. ECG abnormalities in polymyositis. Arch. Intern. Med., 1984, 144, 2185-2189.
42. Alyan, O.; Ozdemir, O.; Geyik, B.; Demirkan, D. Polymyositis complicated with complete atrioventricular block. A case report and review of the literature. Angiology, 2003, 54, 729-731.
43. Pachman, L. M.; Cooke, N. J. Juvenile dermatomyositis: a clinical and immunologic study. Pediatr., 1980, 96, 226-234.
44. Schwartz, T.; Sanner, H.; Husebye, T.; Flato, B.; Sjaastad, I. Cardiac dysfunction in juvenile dermatomyositis: a case-control study. Ann Rheum. Dis., 2011, 70, 766-771.
45. Fathalla, B. M.; Miller, L. C.; Bubolz, B.; Schaller, J. G. Prolonged QTc interval and juvenile dermatomyositis. Clin. Exp. Rheumatol., 2004, 22, 788-789.
46. Mavrogeni, S.; Bratis, K.; Karabela, G.; Stavropoulos, E.; Sfendouraki, E.; Kolovou, G. Myocarditis during acute inflammatory myopathies: evaluation using clinical criteria and cardiac magnetic resonance imaging. Int. J. Cardiol., 2013, 164(1), e3-4.
47. Mavrogeni, S.; Douskou, M.; Manoussakis, M. N. Contrastenhanced CMR imaging reveals myocardial involvement in idiopathic inflammatory myopathy without cardiac manifestations. JACC Cardiovasc. Imaging, 2011, 4(12), 1324-1325.
48. Schwartz, T.; Sjaastad, I.; Flato, B.; Vistnes, M.; Christensen, G.; Sanner, H. In active juvenile dermatomyositis, elevated eotaxin and MCP-1 and cholesterol levels in the upper normal range are associated with cardiac dysfunction. Rheumatology (Oxford), 2014. 53(12), 2214-2222.
49. Mavrogeni, S.; Papadopoulos, G.; Hussain, T.; Chiribiri, A.; Botnar, R.; Greil, G. F. The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease. Int. J. Cardiovasc. Imaging., 2013, 29(8), 1787-1798.
50. Suzuki, A.; Miyagawa-Tomita, S.; Komatsu, K.; Nishikawa, T.; Sakomura, Y.; Horie, T.; Nakazawa, M. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study. Circulation, 2000, 101, 2935-2941.
51. Naoe, S.; Takahashi, K.; Masuda, H.; Tanaka, N. Kawasaki disease with particular emphasis on arterial lesions. Acta Pathol. Jpn., 1991, 41, 785-797.
52. Matsuura, H.; Ishikita, T.; Yamamoto, S.; Umezawa, T.; Ito, R.; Hashiguchi, R.; Saji, T.; Matsuo, N.; Takano, M. Gallium-67 myocardial imaging for the detection of myocarditis in the acute phase of Kawasaki disease (mucocutaneous lymph node syndrome): the usefulness of single photon emission computed tomography. Br. Heart J., 1987, 58, 385-390.
53. Kao, C. H.; Hsieh, K. S.; Wang, Y. L.; Chen, C. W.; Liao, S. Q.; Wang, S. J.; Yeh, S. J. Tc-99m HMPAO labeled WBC scan for the detection of myocarditis in different phases of Kawasaki disease. Clin. Nucl. Med., 1992, 17, 185-190.
54. Mavrogeni, S.; Bratis, K.; Karanasios, E.; Georgakopoulos, D.; Kaklis, S.; Varlamis, G.; Kolovou, G.; Douskou, M.; Papadopoulos, G. CMR evaluation of cardiac involvement during the convalescence of Kawasaki disease. JACC Cardiovasc. Imaging, 2011, 4(10), 1140-1141.
55. Greil, G. F.; Seeger, A.; Miller, S.; Claussen, C. D.; Hofbeck, M.; Botnar, R. M.; Sieverding, L. Coronary magnetic resonance angiography and vessel wall imaging in children with Kawasaki disease. Pediatr. Radiol., 2007, 37(7), 666-673.
56. Mavrogeni, S.; Papadopoulos, G.; Douskou, M.; Kaklis, S.; Seimenis, I.; Baras, P.; Nikolaidou, P.; Bakoula, C.; Karanasios, E.; Manginas, A.; Cokkinos, D. V. Magnetic resonance angiography is equivalent to X-ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease. J. Am. Coll. Cardiol., 2004, 43(4), 649-652.
57. Mavrogeni, S.; Papadopoulos, G.; Douskou, M.; Kaklis, S.; Seimenis, I.; Varlamis, G.; Karanasios, E.; Krikos, X.; Giannoulia, A.; Cokkinos, D. V. Magnetic resonance angiography, function and viability evaluation in patients withKawasaki disease. J. Cardiovasc. Magn. Reson., 2006, 8(3), 493-498.
58. Newburger, J. W.; Takahashi, M.; Gerber, M. A.; Gewitz, M. H.; Tani, L. Y.; Burns, J. C.; Shulman, S. T.; Bolger, A. F.; Ferrieri, P.; Baltimore, R. S.; Wilson, W. R.; Baddour, L. M.; Levison, M. E.; Pallasch, T. J.; Falace, D. A.; Taubert, K. A.; Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease; Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and longterm management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation, 2004, 110(17), 2747-2771.
59. Kato, H.; Sugimura, T.; Akagi, T.; Sato, N.; Hashino, K.; Maeno, Y.; Kazue, T.; Eto, G.; Yamakawa, R. Long-term consequences of Kawasaki disease. A 10-to 21-year follow-up study of 594 patients. Circulation, 1996, 94, 1379-1385.
60. Gupta, A.; Singh, S.; Gupta, A.; Suri, D.; Rohit, M. Aortic stiffness studies in children with Kawasaki disease, preliminary results from a follow-up study from North India. Rheumatol. Int., 2014, 34(10), 1427-1432.
61. Sugimura, T.; Kato, H.; Inoue, O.; Takagi, J.; Fukuda, T.; Sato, N. Vasodilatory response of the coronary arteries after Kawasaki disease: evaluation by intracoronary injection of isosorbide dinitrate. J. Pediatr., 1992, 121, 684-688.
62. Akikusa, J. D.; Schneider, R.; Harvey, E. A.; Hebert, D.; Thorner, P. S.; Laxer, R. M.; Silverman, E. D. Clinical Features and Outcome of Pediatric Wegener's Granulomatosis. Arthritis Rheum., 2007, 57, 837-844.
63. Cabral, D. A.; Uribe, A. G.; Benseler, S.; O'Neil, K. M.; Hashkes, PJ.; Higgins, G.; Zeft, A. S.; Lovell, D. J.; Kingsbury, D. J.; Stevens, A.; McCurdy, D.; Chira, P.; Abramson, L.; Arkachaisri, T.; Campillo, S.; Eberhard, A.; Hersh, A. O.; Huber, A. M.; Kim, S.; Klein-Gitelman, M.; Levy, D. M.; Li, S. C.; Mason, T.; Dewitt, E. M.; Muscal, E.; Nassi, L.; Reiff, A.; Schikler, K.; Singer, N. G.; Wahezi, D.; Woodward, A.; ARChiVe (A Registry for Childhood Vasculitis: e-entry) Investigators Network. Classification, presentation and Initial Treatment of Wegener's Granulomatosis in Childhood. Arthritis Rheum., 2009, 60, 3413-3424.
64. Rottem, M.; Fauci, A. S.; Hallahan, C. W.; Kerr, G. S.; Lebovics, R.; Leavitt, R. Y.; Hoffman, G. S. Wegener granulomatosis in children and adolescents: Clinical presentation and outcome. J. Pediatr., 1993, 122, 26-31.
65. Kosovsky, P. A.; Ehlers, K. H.; Rafal, R. B.; Williams, W. M.; O'Loughlin, J. E.; Markisz, J. A. MR imaging of cardiac mass in Wegener granulomatosis. J. Comput. Assist. Tomogr., 1991, 15, 1028-1030.
66. Harris, J. G.; Salvay, D. M.; Klein-Gitelman, M. S. Asymptomatic intracardiac mass in a 14-year-old girl with granulomatosis with polyangiitis: Case report. Pediatr. Rheumatol. Online J., 2012, 10(1), 9.
67. Kerr, G. S.; Hallahan, C. W.; Giordano, J.; Leavitt, R. Y.; Fauci, A. S.; Rottem, M.; Hoffman, G. S. Takayasu arteritis. Ann. Intern. Med., 1994, 120, 919-929.
68. Szugye, H. S.; Zeft, A. S.; Spalding, S. J. Takayasu Arteritis in the pediatric population: a contemporary United States-Based Single Center Cohort. Pediatr. Rheumatol. Online J., 2014, 12, 21.
69. Berman, D. P.; Lewis, A. B.; Kung, G. C. Case Report of a 2-yearold boy with Takayasu's arteritis: an atypical, severe presentation of a rare disease. Pediatr. Cardiol., 2010, 31(7), 1089-1092.
70. Wang, E. L.; Sato, Y.; Takeichi, T.; Kitamura, O. Sudden death of an infant with coronary involvement due to Takayasu arteritis. Cardiovasc. Pathol., 2013, 22(1), 109-111.
71. Kwon, H. W.; Suh, Y. J.; Bang, J. S.; Kwon, B. S.; Kim, G. B.; Bae, E. J.; Kim, W. H.; Noh, C. I. Aortic valve replacement surgery for a case of infantile Takayasu arteritis. Korean J. Pediatr., 2012, 55(7), 254-258.
72. Sandeep, S.; Unni, V. N.; Sreekumar, K. P.; Mathew, A.; Nair, R. R.; Kurian, G. Takayasu arteritis in an infant. Indian J. Nephrol., 2014, 24(4), 257-259.
73. Brunner, J.; Feldman, B. M.; Tyrrell, P. N.; Kuemmerle-Deschner, J. B.; Zimmerhackl, L. B.; Gassner, I.; Benseler, S. M. Takayasu arteritis in children and adolescents. Rheumatology (Oxford), 2010, 49(10), 1806-1814.
74. Moradinejad, M. H.; Rezaei, A.; Ziaee, V. Juvenile Churg-Strauss syndrome as an etiology of myocarditis and ischemic stroke in adolescents; a case report. Iran J. Pediatr., 2011, 21(4), 530-534.
75. Baszis, K.; Toib, D.; Cooper, M.; French, A.; White, A. Recurrent parotitis as a presentation of primary pediatric Sjogren syndrome. Pediatrics. 2012, 129(1), e179-182.
76. Lieberman, S. M. Childhood Sjogren syndrome: insights from adults and animal models. Curr. Opin. Rheumatol., 2013, 25(5), 651-657.
77. Mavrogeni, S.; Dimitroulas, T.; Gabriel, S.; Sfikakis, P. P.; Pohost, G. M.; Kitas, G. D. Why currently used diagnostic techniques for heart failure in rheumatoid arthritis are not enough: the challenge of cardiovascular magnetic resonance imaging. Rev. Cardiovasc. Med., 2014, 15(4), 320-331.
78. Shivaram, P.; Ahmed, M. I.; Kariyanna, P. T.; Sabbineni, H.; Avula, U. M. Doppler echocardiography imaging in detecting multivalvular lesions: a clinical evaluation inchildren with acute rheumatic fever. PLoS One, 2013, 8(9), e74114.
79. Hilario, M. O.; Andrade, J. L.; Gasparian, A. B.; Carvalho, A. C.; Andrade, C. T.; Len, C. A. The value of echocardiography in the diagnosis and follow up of rheumatic carditis in children and adolescents: a 2 year prospective study. J. Rheumatol., 2000, 27(4), 1082-1086.
80. Colquhoun, S. M.; Kado, J. H.; Remenyi, B.; Wilson, N. J.; Carapetis, J. R.; Steer, A. C. Echocardiographic screening in a resource poor setting: borderline rheumatic heart disease could be a normal variant. Int. J. Cardiol., 2014, 173(2), 284-289.
81. Chung, H. T.; Huang, Y. L.; Yeh, K. W.; Huang, J. L. Subclinical deterioration of left ventricular function in patients with juvenileonset systemic lupus erythematosus. Lupus, 2014, 24(3), 263-272.
82. Schwartz, T.; Sanner, H.; Gjesdal, O.; Flato, B.; Sjaastad, I. In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity. Ann. Rheum. Dis., 2014, 73(10), 1805-1810.
83. Kim, J. W.; Goo, H. W. Coronary artery abnormalities in Kawasaki disease: comparison between CT and MR coronary angiography. Acta Radiol., 2013, 54(2), 156-163.
84. Giacchi, V.; Sciacca, P.; Stella, I.; Filippelli, M.; Barone, P.; La Rosa, M.; Leonardi, S. Assessment of coronary artery intimal thickening in patients with a previous diagnosis of Kawasaki disease by using high resolution transthoracic echocardiography: our experience. BMC Cardiovasc. Disord., 2014, 14, 106.
85. Noto, N.; Kamiyama, H.; Karasawa, K.; Ayusawa, M.; Sumitomo, N.; Okada, T.; Takahashi, S. Long-term prognostic impact of dobutamine stress echocardiography in patients with Kawasaki disease and coronary artery lesions: a 15-year follow-up study. J. Am. Coll. Cardiol., 2014, 63(4), 337-344.
86. McCandless, R. T.; Minich, L. L.; Wilkinson, S. E.; McFadden, M. L.; Tani, L. Y.; Menon, S. C. Myocardial strain and strain rate in Kawasaki disease. Eur. Heart J. Cardiovasc. Imaging, 2013, 14(11), 1061-1068.
87. Kirkpatrick, E. C. Echocardiography in pediatric pulmonary hypertension. Paediatr. Respir. Rev., 2013, 14(3), 157-164.
88. Mostafa, M. S.; Sayed, A. O.; Al Said, Y. M. Assessment of coronary ischaemia by myocardial perfusion dipyridamole stress technetium-99 m tetrofosmin, single-photon emission computed tomography, and coronary angiography in children with Kawasaki disease: preand post-coronary bypass grafting. Cardiol. Young, 2014, 4, 1-8.
89. Mavrogeni, S.; Sfikakis, P. P.; Gialafos, E.; Bratis, K.; Karabela, G.; Stavropoulos, E.; Spiliotis, G.; Sfendouraki, E.; Panopoulos, S.; Bournia, V.; Kolovou, G.; Kitas, G. D. Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases. Arthritis Care Res. (Hoboken), 2014, 66(1), 104-112.
90. Mavrogeni, S.; Manoussakis, M. N. Myocarditis and subclavian stenosis in Takayasu arteritis. Int. J. Cardiol., 2011, 148(2), 223-224.